# To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers

> **NCT02579356** · PHASE1 · COMPLETED · sponsor: **Samil Pharmaceutical Co., Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Diseases of the Circulatory System
- Essential Hypertension

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT02579356
- **Lead sponsor:** Samil Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2015-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02579356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02579356, "To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02579356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*